|
Kwality Pharmaceuticals Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
2460.61 Cr.
|
P/BV
|
8.04
|
Book Value (Rs.)
|
295.01
|
|
52 Week High/Low (Rs.)
|
2440/1561
|
FV/ML
|
10/1
|
P/E(X)
|
36.53
|
|
Bookclosure
|
24/09/2024
|
EPS (Rs.)
|
64.91
|
Div Yield (%)
|
0.01
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 503.08 | 370.20 | 307.17 | 251.03 | 456.19 |
| Total Operating Revenues | 503.08 | 370.20 | 307.17 | 251.03 | 456.19 |
| | | | | | |
| Other Income | 2.86 | 1.92 | 1.83 | 2.94 | 3.51 |
| Total Revenue | 505.94 | 372.12 | 309.00 | 253.97 | 459.70 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 240.81 | 165.41 | 153.81 | 113.22 | 199.31 |
| Purchase Of Stock-In Trade | 17.35 | 15.90 | 0.85 | 0.04 | 3.80 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | 0.28 | 1.17 | -1.48 | -3.20 | -2.51 |
| Employee Benefit Expenses | 54.04 | 43.78 | 32.56 | 29.96 | 20.15 |
| Finance Costs | 10.97 | 9.88 | 10.39 | 6.02 | 2.92 |
| Depreciation And Amortisation Expenses | 19.81 | 18.29 | 19.56 | 14.96 | 10.69 |
| Other Expenses | 72.36 | 63.54 | 55.11 | 50.86 | 63.77 |
| Total Expenses | 415.62 | 317.98 | 270.80 | 211.87 | 298.13 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 90.32 | 54.14 | 38.20 | 42.10 | 161.57 |
| | | | | | |
| Exceptional Items | -0.83 | 0.00 | -7.10 | -16.53 | 0.00 |
| Profit/Loss Before Tax | 89.49 | 54.14 | 31.10 | 25.57 | 161.57 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 22.15 | 14.69 | 7.92 | 6.48 | 41.00 |
| Deferred Tax | 0.00 | -1.59 | -0.44 | 0.14 | 0.27 |
| Tax For Earlier Years | 0.00 | 1.23 | 0.00 | -0.33 | 0.35 |
| Total Tax Expenses | 22.15 | 14.34 | 7.48 | 6.29 | 41.63 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 67.35 | 39.80 | 23.62 | 19.28 | 119.94 |
| | | | | | |
| Profit/Loss From Continuing Operations | 67.35 | 39.80 | 23.62 | 19.28 | 119.94 |
| | | | | | |
| Profit/Loss For The Period | 67.35 | 39.80 | 23.62 | 19.28 | 119.94 |
| | | | | | |
| Minority Interest | 0.03 | 0.04 | 0.18 | 0.09 | 0.05 |
| Consolidated Profit/Loss After MI And Associates | 67.35 | 39.85 | 23.80 | 19.37 | 119.99 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | 64.90 | 38.36 | 22.76 | 18.16 | 115.64 |
| Diluted EPS (Rs.) | 0.00 | 38.36 | 22.76 | 18.16 | 115.64 |
